Do platelet-derived microparticles play a role in depression, inflammation, and acute coronary syndrome?

Psychosomatics

Volumn 55, Issue 3, 2014, Pages 252-260

  Williams, Marlene S ^a   Rogers, Heather L ^b   Wang, Nae Yuh ^a   Ziegelstein, Roy C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF DEUSTO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; INTERLEUKIN 6; SEROTONIN; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL6 PROTEIN, HUMAN;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BECK DEPRESSION INVENTORY; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; DEPRESSION; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPERTENSION; INFLAMMATION; MALE; MEDICAL HISTORY; MIDDLE AGED; PATIENT HEALTH QUESTIONNAIRE 9; PLATELET MICROPARTICLE; SMOKING; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FREE PLASMA; THROMBOCYTE FUNCTION; THROMBOSIS; AGED; BLOOD; IMMUNOLOGY; MEMBRANE MICROPARTICLE; THROMBOCYTE; VERY ELDERLY;

ACUTE CORONARY SYNDROME; AGED; AGED, 80 AND OVER; BIOMARKERS; BLOOD PLATELETS; C-REACTIVE PROTEIN; CELL-DERIVED MICROPARTICLES; DEPRESSION; FEMALE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PLATELET ACTIVATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84899637747     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.09.004     Document Type: Article

References (31)

1. Amin A.A., Jones A.M., Nugent K., Rumsfeld J.S., Spertus J.A. The prevalence of unrecognized depression in patients with acute coronary syndrome. Am Heart J 2006, 152:928-934.
2. Frasure-Smith N., Lesperance F., Talajic M. Depression following myocardial infarction. Impact on 6-month survival. J Am Med Assoc 1993, 270:1819-1825.
3. Bush D.E., Ziegelstein R.C., Tayback M., et al. Even minimal symptoms of depression increase mortality risk after acute myocardial infarction. Am J Cardiol 2001, 88:337-341.
4. Ambrose J.A. Plaque disruption and the acute coronary syndromes of unstable angina and myocardial infarction: if the substrate is similar, why is the clinical presentation different?. J Am Coll Cardiol 1992, 19:1653-1658.
5. Cohen M. Treatment of unstable angina: the role of platelet inhibitors and anticoagulants. J Invasive Cardiol 1999, 11:147-159.
6. Musselman D.L., Tomer A., Manatunga A.K., et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry 1996, 153:1313-1317.
7. Shimbo D., Child J., Davidson K., et al. Exaggerated serotonin-mediated platelet reactivity as a possible link in depression and acute coronary syndromes. Am J Cardiol 2002, 89:331-333.
8. Markovitz J.H., Shuster J.L., Chitwood W.S., May R.S., Tolbert L.C. Platelet activation in depression and effects of sertraline treatment: an open-label study. Am J Psychiatry 2000, 157:1006-1008.
9. Pollock B.G., Laghrissi-Thode F., Wagner W.R. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol 2000, 20:137-140.
10. Laghrissi-Thode F., Wagner W.R., Pollock B.G., Johnson P.C., Finkel M.S. Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease. Biol Psychiatry 1997, 42:290-295.
11. Italiano J.E., Mairuhu A.T., Flaumenhaft R. Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 2010, 17:578-584.
12. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory II 1996, Psychological Corporation, San Antonio, TX.
13. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
14. Lichtman J.H., Bigger J.T., Blumenthal J.A., et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008, 118:1768-1775.
15. Hammash M.H., Hall L.A., Lennie T.A., et al. Psychometrics of the PHQ-9 as a measure of depressive symptoms in patients with heart failure. Eur J Cardiovasc Nurs 2012, 12:446-453.
16. Cameron I.M., Cardy A., Crawford J.R., et al. Measuring depression severity in general practice: discriminatory performance of the PHQ-9, HADS-D, and BDI-II. Br J Gen Pract 2011, 61:e419-e426.
17. Williams M.S., Kickler T.S., Vaidya D., Ng'alla L.S., Bush D.E. Evaluation of platelet function in aspirin treated patients with CAD. J Thromb Thrombolysis 2006, 21:241-247.
18. Boulanger C.M., Amabile N., Tedgui A. Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 2006, 48:180-186.
19. Mause S.F., Weber C. Microparticles: protagonists of a novel communication network for intercellular information exchange. Circ Res 2010, 107:1047-1057.
20. Mallat Z., Benamer H., Hugel B., et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation 2000, 101:841-843.
21. Skeppholm M., Mobarrez F., Malmqvist K., Wallen H. Platelet-derived microparticles during and after acute coronary syndrome. Thromb Haemost 2012, 107:1122-1129.
22. Lindahl B., Toss H., Siegbahn A., Venge P., Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. New Engl J Med 2000, 343:1139-1147.
23. Sukhija R., Fahdi I., Garza L., et al. Inflammatory markers, angiographic severity of coronary artery disease, and patient outcome. Am J Cardiol 2007, 99:879-884.
24. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009, 71:171-186.
25. Bergandi L., Cordero M., Anselmino M., et al. Altered nitric oxide/cGMP platelet signaling pathway in platelets from patients with acute coronary syndromes. Clin Res Cardiol 2010, 99:557-564.
26. Wulsin L.R., Musselman D., Otte C., Bruce E., Ali S., Whooley M.A. Depression and whole blood serotonin in patients with coronary heart disease from the Heart and Soul Study. Psychosom Med 2009, 71:260-265.
27. Serra-Millas M., Lopez-Vilchez I., Navarro V., et al. Changes in plasma and platelet BDNF levels induced by S-citalopram in major depression. Psychopharmacology 2011, 216:1-8.
28. Bruce E.C., Musselman D.L. Depression, alterations in platelet function, and ischemic heart disease. Psychosom Med 2005, 67(1 Suppl):S34-S36.
29. Garcia-Sevilla J.A., Garcia-Vallejo P., Guimon J. Enhanced alpha 2-adrenoceptor-mediated platelet aggregation in patients with major depressive disorder. Eur J Pharmacol 1983, 94:359-360.
30. Garcia-Sevilla J.A., Padro D., Giralt M.T., Guimon J., Areso P. Alpha 2-adrenoceptor-mediated inhibition of platelet adenylate cyclase and induction of aggregation in major depression. Effect of long-term cyclic antidepressant drug treatment. Arch Gen Psychiatry 1990, 47:125-132.
31. Musselman D.L., Marzec U.M., Manatunga A., et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000, 57:875-882.